Biogena Group Invest AG (WBO:BIO) Accounts Receivable : €0.00 Mil (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Biogena Group Invest AG's accounts receivables for the quarter that ended in Jan. 2024 was €0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Biogena Group Invest AG's Days Sales Outstanding for the quarter that ended in Jan. 2024 was 4.40.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Biogena Group Invest AG's Net-Net Working Capital per share for the quarter that ended in Jan. 2024 was €-0.09.

Biogena Group Invest AG Accounts Receivable Historical Data

The historical data trend for Biogena Group Invest AG's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Accounts Receivable Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Accounts Receivable

0.18

0.35

0.04

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Accounts Receivable	0.18	0.35	0.04	-

Biogena Group Invest AG Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Biogena Group Invest AG Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Biogena Group Invest AG's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.004	/	0.166	*	91
=	4.40

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Biogena Group Invest AG's accounts receivable are only considered to be worth 75% of book value:

Biogena Group Invest AG's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.023	+	0.75 * 0.004	+	0.5 * 0	-	0.366
-	0	-	0)	/	3.99
=	-0.09

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Biogena Group Invest AG Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.